Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease

Table 6 Post-operative risks of complications with ulcerative colitis

Authors	Complications	Cases (%)	Controls (%)	Risks of complications, OR (95% CI)
Selvasekar[25]	Pouch specific	19	7	2.6 (0.9-7.5)
	Infectious	28	10	2.7 (1.1-6.7)
Schluender[26]	Medical	6	10	0.6 (0.1-4.8)
	Surgical	30	18	1.9 (0.6-5.9)
	Infectious	18	8	2.4 ( 0.6-9.6)
Mor[27]	Early	35	15	3.5 (1.5-8.3)
	Late	52	37	2.2 (0.9-5.3)
	Sepsis	22	1	13.8 (1.8-105)
Ferrante[28]	Pouch specific	0	17	0.9 (0.8-0.9)
	Surgical infections	11	23	0.2 (0.03-1.6)
	Total Infectious	11	28.60	0.3 (0.07-1.4)
Kunitake[29] (combined study)	Post-operative cumulative complications	16.80	15.70	1.1 (0.6-2.0)

OR: Odd ratio; CI: Confidence interval.